Abstract
Background and objectives
Although indomethacin has been widely used for the treatment of preterm labor over the past 40 years, there are few reports regarding its pharmacokinetics in pregnant women.
Methods
This opportunistic study assessed the steady-state pharmacokinetics of indomethacin in pregnant subjects to whom an oral dose of 25 mg every 6 h was prescribed. Indomethacin concentrations in plasma and urine were analyzed by a validated high-performance liquid chromatography method with mass spectrometric detection.
Results
The mean area under the plasma concentration versus time curve at steady state (AUCss) was 1.91 ± 0.53 μg·h/mL, mean peak plasma concentration (C max) was 1.02 ± 0.49 μg/mL, and mean time to reach C max (t max) was 1.3 ± 0.7 h. The mean apparent clearance at steady state was 14.5 ± 5.5 L/h, which is higher than the apparent clearance reported in the literature for non-pregnant subjects. Indomethacin crosses the placenta; the mean fetal/maternal ratio from five sets of cord blood samples collected at delivery was 4.0 ± 1.1.
Conclusions
Further studies are needed to determine whether any dose adjustments are necessary as a result of the increased clearance of indomethacin during pregnancy.
Similar content being viewed by others
References
Gamissans O, Balasch J. Prostaglandin synthetase inhibitors in the treatment of preterm birth. In: Fuchs A-R, Stubblefield PG, Fuchs F, editors. Preterm birth: causes, prevention, and management. 2nd ed. New York: McGraw-Hill; 1993. p. 309–32.
Zuckerman H, Shalev E, Gilad G, et al. Further study of the inhibition of premature labor by indomethacin. Part II: double-blind study. J Perinatal Med. 1984;12:25–9.
Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obst Gynecol. 1974;44:787–92.
Wiqvist N. Endogenous prostaglandins in normal pregnancy and labor. Pharmacol Ther B. 1975;1:297–310.
Rane A, Oelz O, Frolich JC, et al. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther. 1978;23:658–68.
Helleberg L. Clinical Pharmacokinetics of indomethacin. Clin Pharmacokinet. 1981;6:245–58.
Alván G, Orme M, Bertilsson L, et al. Pharmacokinetics of indomethacin. Clin Pharmacol Ther. 1975;18:364–73.
Abramovici A, Cantu J, Jenkins SM. Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin N Am. 2012;39:77–87.
Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet. 1997;33:328–43.
Wang X, Vernikovskaya DI, Nanovskaya TN, et al. A liquid chromatography method with single quadrupole mass spectrometry for quantitative determination of indomethacin in maternal plasma and urine of pregnant patients. J Pharm Biomed Anal. 2013;78–79:123–8.
Soback S, Britzi M. Absorption-dependent apparent volume of distribution at steady state (Vss/F) in pharmacokinetic data analysis. J Vet Pharmacol Ther. 2011;34:512–4.
Hakkola J, Raunio H, Purkunen R, et al. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol. 1996;52:379–83.
Niebyl JR, Blake DA, White RD, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol. 1980;136:1014–9.
Jeyabalan A, Caritis SN. Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol. 2002;45:99–113.
Baber N, Halliday LD, van den Heuvel WJ, et al. Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders. Ann Rheum Dis. 1979;38:128–36.
Traeger A, Noschel H, Zaumseil J. Pharmacokinetics of indomethacin in pregnant and parturient women and in their newborn infants. Zentralbl Gynakol. 1973;95:635–41.
Burton ME, Shaw LM, Schentag JJ, et al., editors. Applied pharmacokinetics and pharmacodynamics: principles of therapeutic drug monitoring. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
Vree TB, Biggelaar-Martea M, Verwey-van Wissen CP. Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis: preliminary pharmacokinetics and effect of probenecid. J Chromatogr. 1993;616:271–82.
Nakajima M, Inoue T, Shimada N, et al. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Drug Metab Disp. 1998;26:261–6.
Hebert MF. Impact of pregnancy on maternal pharmacokinetics of medications. In: Mattison DR, editor. Clinical pharmacology during pregnancy. San Diego: Elsevier; 2013. p. 17–40.
Choi SY, Koh KH, Jeong H. Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013;41:263–9.
Moise KJ Jr, Ou CN, Kirshon B, et al. Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol. 1990;162:549–54.
Kirshon B, Moise KJ Jr, Mari G, et al. Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios. Am J Perinatol. 1991;8:86–8.
Rainsford KD, James C, Hunt RH, et al. Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers. Clin Pharmacol Ther. 1992;51:415–21.
Acknowledgments
This work was supported by grant U10HD047891 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Obstetrical Pharmacology Research Units Network (OPRU), to G.D.V. Hankins. The authors sincerely appreciate the support of the physicians and nurses of the Labor and Delivery Ward at John Sealy Hospital, the teaching hospital at the University of Texas Medical Branch, Galveston, Texas, nursing coordinator Aimee Jackson, and the Perinatal Research Division of the Department of Obstetrics and Gynecology. Dawn Fischer, RN, from the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, is also thanked for her assistance. Erik Rytting, Tatiana N. Nanovskaya, Xiaoming Wang, Daria I. Vernikovskaya, Shannon M. Clark, Marlo Cochran, Susan M. Abdel-Rahman, Raman Venkataramanan, Steve N. Caritis, Gary D.V. Hankins, and Mahmoud S. Ahmed have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rytting, E., Nanovskaya, T.N., Wang, X. et al. Pharmacokinetics of Indomethacin in Pregnancy. Clin Pharmacokinet 53, 545–551 (2014). https://doi.org/10.1007/s40262-014-0133-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40262-014-0133-6